Skip to main content

UroGen Pharma Ltd.

URGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001668243

In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by UroGen Pharma Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
2 insiders, $3.36M in total
Insiders trading
2
Net value
−$3.36M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for UroGen Pharma Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for UroGen Pharma Ltd.
NameTitleLast reported holdingLast filingFilings, past year
Schoenberg MarkChief Medical Officer59,882Sep 9, 20269
Smith Jason DrewGeneral Counsel53,141Sep 9, 20262
Robinson James A. Jr.Director8,000Aug 28, 20265
Butitta Cynthia MDirector2,000Jun 24, 20262
Belldegrun ArieDirector408,693Jun 24, 20261
Holden StuartDirector2,000Jun 24, 20262
Wen LeanaDirector2,000Jun 24, 20262
Wildman Daniel GeorgeDirector2,000Jun 24, 20262
Barrett Elizabeth A.Chief Executive Officer326,691Feb 19, 20261
Degnan ChrisChief Financial Officer2,280Feb 3, 20262
Kim DongChief Financial Officer37,753Sep 12, 20240
Cohen Fred EDirector69,339IndirectAug 8, 20240
Nussbaum RanDirector1,434,958IndirectFeb 28, 20230
Henderson MollyChief Financial Officer5,248Feb 2, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 9, 2026 (view filing)2:37 PM ETSep 81 daySchoenberg MarkChief Medical OfficerSSale−871$42.92−$37.4K−1.4%59.9K after
Sep 9, 2026 (view filing)2:35 PM ETSep 81 daySmith Jason DrewGeneral CounselSSale−1.52K$42.54−$64.6K−2.8%53.1K after
Aug 24, 2026 (view filing)5:03 PM ETAug 204 daysSchoenberg MarkChief Medical OfficerSSale−60.7K$47.05−$2.85M−50.7%59.1K after
Jul 10, 2026 (view filing)2:17 PM ETJul 91 daySchoenberg MarkChief Medical OfficerSSale−10.0K$40.00−$400.0K−7.7%119.8K after10b5-1
Jun 24, 2026 (view filing)Jun 222 daysSchoenberg MarkChief Medical OfficerSSale−10.0K$35.01−$350.1K−7.2%129.8K after10b5-1
Jun 9, 2026 (view filing)Jun 81 daySchoenberg MarkChief Medical OfficerSSale−5.22K$27.30−$142.6K−3.6%139.8K after
May 11, 2026 (view filing)May 83 daysSchoenberg MarkChief Medical OfficerSSale−10.0K$30.00−$300.0K−6.9%135.0K after10b5-1
Feb 11, 2026 (view filing)Feb 38 daysLateSmith Jason DrewGeneral CounselSSale−7.48K$19.69−$147.3K−11.9%55.6K after3 lots
Feb 4, 2026 (view filing)Feb 31 daySchoenberg MarkChief Medical OfficerSSale−7.37K$19.69−$145.2K−4.8%145.0K after3 lots
Nov 20, 2025 (view filing)Nov 191 daySchoenberg MarkChief Medical OfficerSSale−10.0K$25.00−$250.0K−6.7%139.0K after10b5-1
Oct 9, 2025 (view filing)Oct 81 dayDegnan ChrisChief Financial OfficerSSale−2.20K$16.85−$37.1K−49.1%2.28K after
Sep 9, 2025 (view filing)Sep 81 daySchoenberg MarkChief Medical OfficerSSale−871$19.11−$16.6K−0.6%149.0K after
Sep 9, 2025 (view filing)Sep 81 daySmith Jason DrewGeneral CounselSSale−1.52K$19.11−$29.0K−3.4%43.3K after
Aug 13, 2025 (view filing)Aug 112 daysSchoenberg MarkChief Medical OfficerSSale−10.0K$17.69−$176.9K−6.3%148.2K after
Jul 30, 2025 (view filing)Jul 282 daysSmith Jason DrewGeneral CounselSSale−7.52K$19.14−$144.0K−15.3%41.5K after
Jul 30, 2025 (view filing)Jul 282 daysSchoenberg MarkChief Medical OfficerSSale−5.15K$19.14−$98.6K−3.2%158.2K after
Jun 11, 2025 (view filing)Jun 92 daysSchoenberg MarkChief Medical OfficerSSale−5.16K$7.37−$38.0K−3.3%153.4K after
Feb 4, 2025 (view filing)Jan 314 daysSchoenberg MarkChief Medical OfficerSSale−4.55K$11.14−$50.7K−3.0%148.5K after3 lots
Feb 4, 2025 (view filing)Jan 314 daysSmith Jason DrewGeneral CounselSSale−7.38K$11.14−$82.2K−18.5%32.5K after3 lots
Sep 12, 2024 (view filing)Sep 93 daysLateSchoenberg MarkChief Medical OfficerSSale−859$13.08−$11.2K−0.6%145.1K after
Sep 12, 2024 (view filing)Sep 93 daysLateSmith Jason DrewGeneral CounselSSale−1.52K$13.08−$19.9K−5.7%25.2K after
Jun 11, 2024 (view filing)Jun 101 daySchoenberg MarkChief Medical OfficerSSale−5.15K$13.08−$67.4K−3.4%144.3K after
Mar 20, 2024 (view filing)Mar 182 daysSchoenberg MarkChief Medical OfficerSSale−12.0K$14.05−$168.6K−7.9%139.4K after
Feb 5, 2024 (view filing)Feb 14 daysSmith Jason DrewGeneral CounselSSale−4.99K$15.78−$78.8K−17.6%23.4K afterAmended3 lots
Feb 5, 2024 (view filing)Feb 14 daysSchoenberg MarkChief Medical OfficerSSale−3.79K$15.78−$59.8K−2.4%151.4K afterAmended3 lots
Feb 2, 2024 (view filing)Jan 312 daysSmith Jason DrewGeneral CounselSSale−4.99K$15.74−$78.6K−17.6%23.4K afterFrom original3 lots
Feb 2, 2024 (view filing)Jan 312 daysSchoenberg MarkChief Medical OfficerSSale−3.79K$15.74−$59.6K−2.4%151.4K afterFrom original3 lots
Sep 5, 2023 (view filing)Aug 315 daysSmith Jason DrewGeneral CounselSSale−3.80K$18.01−$68.4K−17.1%18.4K after
Feb 2, 2023 (view filing)Jan 312 daysSmith Jason DrewGeneral CounselSSale−1.64K$10.12−$16.6K−10.5%13.9K after2 lots
Feb 2, 2023 (view filing)Jan 312 daysSchoenberg MarkChief Medical OfficerSSale−1.90K$10.12−$19.2K−1.3%148.6K after3 lots
Nov 2, 2022 (view filing)Oct 312 daysSchoenberg MarkChief Medical OfficerSSale−258$11.85−$3.06K−1.1%23.9K after
Sep 2, 2022 (view filing)Aug 312 daysSmith Jason DrewGeneral CounselSSale−3.61K$7.21−$26.0K−22.8%12.2K after
Aug 25, 2022 (view filing)Aug 124 daysLateSchoenberg MarkChief Medical OfficerSSale−259$7.81−$2.02K−1.1%23.7K after
May 3, 2022 (view filing)Apr 303 daysSchoenberg MarkChief Medical OfficerSSale−254$6.62−$1.68K−1.1%23.5K after
Feb 2, 2022 (view filing)Jan 312 daysSmith Jason DrewGeneral CounselSSale−414$7.58−$3.14K−5.3%7.45K after
Feb 2, 2022 (view filing)Jan 312 daysHenderson MollyChief Financial OfficerSSale−331$7.58−$2.51K−5.9%5.25K after
Feb 2, 2022 (view filing)Jan 312 daysSchoenberg MarkChief Medical OfficerSSale−1.37K$7.58−$10.4K−5.6%23.2K after2 lots
Feb 2, 2022 (view filing)Jan 312 daysBarrett Elizabeth A.Chief Executive OfficerSSale−8.20K$7.58−$62.1K−2.6%308.4K after2 lots
Jan 28, 2022 (view filing)Jan 262 daysSchoenberg MarkChief Medical OfficerSSale−111$8.09−$897.99−0.5%22.1K after
Jan 7, 2022 (view filing)Jan 43 daysLateBarrett Elizabeth A.Chief Executive OfficerSSale−47.0K$9.15−$429.8K−13.6%298.2K after
Dec 2, 2021 (view filing)Nov 302 daysSmith Jason DrewGeneral CounselSSale−3.80K$12.03−$45.8K−35.1%7.03K after
Dec 2, 2021 (view filing)Nov 302 daysHenderson MollyChief Financial OfficerSSale−2.59K$12.03−$31.1K−34.5%4.91K after
Nov 19, 2021 (view filing)Nov 181 daySchoenberg MarkChief Medical OfficerPPurchase+160$13.10+$2.10K+0.7%22.0K after
Nov 2, 2021 (view filing)Nov 11 daySchoenberg MarkChief Medical OfficerSSale−258$17.16−$4.43K−1.2%21.8K after
Oct 28, 2021 (view filing)Oct 271 daySchoenberg MarkChief Medical OfficerSSale−107$16.32−$1.75K−0.5%21.6K after
Aug 3, 2021 (view filing)Aug 21 daySchoenberg MarkChief Medical OfficerSSale−243$15.64−$3.80K−1.1%21.5K after
Jul 28, 2021 (view filing)Jul 262 daysSchoenberg MarkChief Medical OfficerSSale−103$15.30−$1.58K−0.5%20.8K after